WEI HU to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications WEI HU has written about Clinical Trials, Phase I as Topic.
Connection Strength
0.007
-
DNA image cytometric measurement as a surrogate end point biomarker in a phase I trial of alpha-difluoromethylornithine for cervical intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev. 1997 Oct; 6(10):849-55.
Score: 0.007